Thank you, Mr. Chair.
On the question of whether there is duplication in terms of hopefully better health outcomes for clients and Canadians, I'm interested in knowing why, although the Federal Healthcare Partnership has representation on CDR, at least three of the federal drug plans do not? I'm not clear on that.
There also seems to be some discrepancy there as to why two organizations—I'm forgetting which two—I believe, have representation on behalf of the organization, but the others are all separate.